Gaucher Disease

Gaucher disease is an autosomal-recessive deficiency of glucocerebrosidase causing glucocerebroside accumulation in macrophages (Gaucher cells). Type 1 (non-neuronopathic, most common): hepatosplenomegaly, anemia, thrombocytopenia, bone pain/crises, osteoporosis, bleeding. Type 2/3 are neuronopathic with neurologic involvement. Treatment: enzyme-replacement therapy (imiglucerase) or substrate-reduction therapy; supportive bone/blood management.

Common Symptoms

Hepatosplenomegaly; anemia/thrombocytopenia; bone pain/crises; easy bruising; fatigue; neurologic signs (type 2/3)

Causes and Pathogenesis

Glucocerebrosidase deficiency causes glucocerebroside-laden macrophages infiltrating liver/spleen/bone marrow, causing cytopenias and bone disease.

Treatment

Enzyme-replacement therapy; substrate-reduction therapy; supportive (transfusion, orthopedic care)

Preventive Measures

Genetic screening (Ashkenazi Jewish); carrier screening; early treatment.

Department to Visit

It is recommended to visit the Hematology department; an appointment can be booked on this platform before the visit.

Warm reminder: The above information is for health science reference only and cannot replace professional medical diagnosis. If you have related symptoms, please seek medical attention at a regular hospital promptly.